From the Division of Endocrinology (K.K., M.T.H., M.L.T.) and Vascular
Biopharmacology/Renin Biochemistry Laboratories (J.-H.Z., J.D.B., P.E.),
Department of Veterans Affairs Medical Center, Sepulveda, Calif; and
University of California at Los Angeles School of Medicine.
Correspondence to Michael L. Tuck, MD, Division of Endocrinology (111E), VA Medical Center, 16111 Plummer St, Sepulveda, CA 91343. E-mail mtuck{at}ucla.edu
AbstractInsulin has been
shown to directly affect blood vessel tone and to promote vascular
hypertrophy, but the mechanism of these actions remains
uncertain. Because angiotensin I (Ang I)converting enzyme
inhibitors have been shown to improve insulin action and to
impede the progression of vascular hypertrophy in
hypertensive animal models, it is possible that the vascular properties
of insulin may be mediated through the tissue
renin-angiotensin system (RAS). To evaluate this
relationship, we first investigated the effect of insulin on components
of the RAS using cultured rat vascular smooth muscle cells (VSMCs).
Insulin treatment (1000 µU/mL) markedly increased
angiotensinogen mRNA expression and
angiotensinogen production. We next investigated
the role of the RAS in insulin-mediated cell proliferation, using
[3H]thymidine uptake. Studies were done both with insulin
alone and in the presence of captopril (1x10-7 to
10-5 mol/L) and losartan (1x10-9 to
10-7 mol/L). [3H]Thymidine uptake was
increased significantly by 1000 µU/mL insulin, and this stimulation
was reduced by 1x10-6 mol/L captopril (-38.8%,
P<0.05) and by 1x10-8 mol/L
losartan (-37.5%, P<0.05). Further studies
showed that the degree of insulin-mediated [3H]thymidine
uptake in VSMCs could be duplicated by 4x10-10 mol/L Ang
II. Losartan reduced the effects of both Ang II and insulin on
[3H]thymidine uptake by about 40% to 45% of baseline
(P<0.05). Captopril reduced insulin-mediated
[3H]thymidine uptake but did not affect Ang IImediated
[3H]thymidine uptake. In summary, insulin induced
significant stimulation of angiotensinogen expression and
production and stimulated growth similar to that seen with Ang
II in cultured rat VSMCs. Inhibition of Ang II production or
its binding to the Ang II type 1 (AT1) receptor inhibited
insulin-mediated growth in a fashion similar to that seen with
inhibition of Ang IImediated growth. Thus, insulin can modulate the
vascular RAS, and the effect of insulin on vascular growth may be via
direct effects on angiotensinogen expression and
translation operative through both the AT1 receptor and the
conversion of Ang I to Ang II.
© 1998 American Heart Association, Inc.
Scientific Contributions
Insulin-Mediated Growth in Aortic Smooth Muscle and the Vascular Renin-Angiotensin System
Key Words: angiotensinogen angiotensin II insulin muscle, smooth, vascular
This article has been cited by other articles:
![]() |
M. E. Johansson, I. J. Andersson, C. Alexanderson, O. Skott, A. Holmang, and G. Bergstrom Hyperinsulinemic rats are normotensive but sensitized to angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1240 - R1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Perlstein, M. Gerhard-Herman, N. K. Hollenberg, G. H. Williams, and A. Thomas Insulin Induces Renal Vasodilation, Increases Plasma Renin Activity, and Sensitizes the Renal Vasculature to Angiotensin Receptor Blockade in Healthy Subjects J. Am. Soc. Nephrol., March 1, 2007; 18(3): 944 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kobayashi, Y. Hayashi, K. Taguchi, T. Matsumoto, and K. Kamata ANG II enhances contractile responses via PI3-kinase p110{delta} pathway in aortas from diabetic rats with systemic hyperinsulinemia Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H846 - H853. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Li, T.-X. Cui, T. Shiuchi, H.-W. Liu, L.-J. Min, M. Okumura, T. Jinno, L. Wu, M. Iwai, and M. Horiuchi Nicotine Enhances Angiotensin II-Induced Mitogenic Response in Vascular Smooth Muscle Cells and Fibroblasts Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 80 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Begum and L. Ragolia High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation Am J Physiol Cell Physiol, January 1, 2000; 278(1): C81 - C91. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |